Page last updated: 2024-08-23

diaziquone and Leukemia

diaziquone has been researched along with Leukemia in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19906 (85.71)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balis, FM; Blaney, SM; Poplack, DG1
Dicke, KA; Spitzer, G1
Ettinger, LJ; Hammond, GD; Krailo, M; Krivit, W; Ruccione, KS1
Davis, RB; Lee, EJ; Mayer, RJ; Peterson, BA; Schiffer, CA1
Egorin, MJ; Lee, EJ; Nayar, MS; Schiffer, CA; Shulman, P; Van Echo, DA1
Bachur, NR; Egorin, MJ; Fox, BM; Friedman, RD; Gutierrez, PL; Spiegel, JF1
Bachur, NR; Egorin, MJ; Fox, BM; Friedman, R; Gutierrez, PL1

Reviews

1 review(s) available for diaziquone and Leukemia

ArticleYear
Evaluation of the use of high-dose cytoreduction with autologous marrow rescue in various malignancies.
    Transplantation, 1986, Volume: 41, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Bone Marrow Diseases; Bone Marrow Transplantation; Breast Neoplasms; Carcinoma, Small Cell; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Evaluation; Hodgkin Disease; Humans; Leukemia; Lung Neoplasms; Lymphoma; Neoplasm Metastasis; Neoplasms; Neuroblastoma; Transplantation, Autologous

1986

Other Studies

6 other study(ies) available for diaziquone and Leukemia

ArticleYear
Pharmacologic approaches to the treatment of meningeal malignancy.
    Oncology (Williston Park, N.Y.), 1991, Volume: 5, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Agents; Aziridines; Benzoquinones; Blood-Brain Barrier; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Humans; Infant; Infant, Newborn; Leukemia; Meningeal Neoplasms; Mercaptopurine; Methotrexate; Thiotepa

1991
A phase II study of diaziquone in childhood leukemia: a report from the Children's Cancer Study Group.
    The American journal of pediatric hematology/oncology, 1988,Spring, Volume: 10, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Bone Marrow Diseases; Brain Neoplasms; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Leukemia; Male

1988
Combination chemotherapy with diaziquone and amsacrine in relapsed and refractory acute nonlymphocytic leukemia: a Cancer and Leukemia Group B Study.
    Cancer treatment reports, 1987, Volume: 71, Issue:9

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Amsacrine; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Female; Humans; Leukemia; Male; Middle Aged

1987
Diaziquone given as a continuous infusion is an active agent for relapsed adult acute nonlymphocytic leukemia.
    Blood, 1986, Volume: 67, Issue:1

    Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Female; Humans; Kinetics; Leukemia; Male; Middle Aged; Platelet Count; Recurrence

1986
Cellular pharmacology in murine and human leukemic cell lines of diaziquone (NSC 182986).
    Cancer research, 1985, Volume: 45, Issue:3

    Topics: Animals; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Carbon Radioisotopes; Cell Division; Cell Line; Free Radicals; Humans; Leukemia; Mice; Oxygen Consumption; Thymidine; Uridine

1985
Cellular activation of diaziquone [2,5-diaziridinyl-3,6-bis (carboethoxyamino)-1,4-benzoquinone] to its free radical species.
    Biochemical pharmacology, 1985, May-01, Volume: 34, Issue:9

    Topics: Animals; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Cell Line; Ethylmaleimide; Free Radicals; Humans; Kinetics; Leukemia; Leukemia L1210; Mice; NADP; Oxygen Consumption

1985